Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Breaking News: Business Science Business News
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Breaking news Companies Health care industry
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Novo Nordisk A/S US: News Eli Lilly and Co
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Biotechnology Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Biotech and Pharmaceuticals Biotechnology Business News
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Eli Lilly and Co US: News Novo Nordisk A/S
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Mobile Apple Inc Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Daily Open Novo Nordisk A/S Hess Corp
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Consumer prices Intel Corp Asia Markets
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investment strategy Novo Nordisk A/S Health care industry
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Walgreens Boots Alliance Inc Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Medication Health care industry Exercise
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Health & Science Pharmaceuticals Earnings
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIRK EVS MSFT NVO
Tags Tempest Therapeutics NVO Benzinga
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
Tags Abbott Laboratories Dexcom Inc Business
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Business Plug Power Inc Economy
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Humana Inc Timken Co Novo Nordisk A/S
From CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
Tags Europe Markets Novo Nordisk A/S LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Mergers and acquisitions Health & Science Pharmaceuticals
From CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
Tags Markets Charles Schwab Corp Goldman Sachs Group Inc
From CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Tags US: News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
Tags Investment strategy Marathon Petroleum Corp Carrier Global Corp
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Amgen Inc Abbvie Inc AstraZeneca PLC
From CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
Tags Health care industry Hostess Brands Inc Business
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Tags Health care industry Business Companies
From CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
Tags Biotech and Pharmaceuticals Biotechnology US: News
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Social issues US: News Eli Lilly and Co
From CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Tags Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
Tags CNBC Investing Club: Analysis J M Smucker Co Breaking News: Markets
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Health care industry Business Diabetes
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.